A Hierarchical Bayesian Design for Phase I Trials of Novel Combinations of Cancer Therapeutic Agents

DOI10.1111/j.1541-0420.2009.01363.xzbMath1203.62181WikidataQ41241253 ScholiaQ41241253MaRDI QIDQ3064270

Shufang Wang, Thomas M. Braun

Publication date: 21 December 2010

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc2889231

zbMATH Keywords

Bayesian statistics; adaptive design; dose-finding study; two dimensional; dose-escalation study

Mathematics Subject Classification ID

62P10: Applications of statistics to biology and medical sciences; meta analysis

62F15: Bayesian inference

92C50: Medical applications (general)

Related Items

A Bayesian adaptive design in cancer phase I trials using dose combinations in the presence of a baseline covariate, Adaptive clinical trial designs for phase I cancer studies

Cites Work

• Unnamed Item
• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
• Continual Reassessment Method for Ordered Groups
• Dose-Finding with Two Agents in Phase I Oncology Trials
• Design and Analysis of Phase I Clinical Trials
• Designs for Single- or Multiple-Agent Phase I Trials
• Continual Reassessment Method: A Likelihood Approach
• Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials
• Two‐Dimensional Dose Finding in Discrete Dose Space